• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dexcom Inc (NQ: DXCM )

    68.11 +2.43 (+3.70%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,336,536
    Open 66.45
    Bid (Size) 67.40 (1)
    Ask (Size) 68.13 (3)
    Prev. Close 65.68
    Today's Range 66.22 - 68.99
    52wk Range 62.34 - 142.00
    Shares Outstanding 400,700,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    2 Beaten-Down Growth Stocks You Might Regret Not Buying
    Their headwinds won't last forever. 
    Via The Motley Fool
    Is DexCom a Millionaire Maker?
    The company's game-changing technology could improve the lives of hundreds of millions of patients. 
    Via The Motley Fool

    Performance

    YTD
    -44.67%
    -44.67%
    1 Month
    -2.45%
    -2.45%
    3 Month
    -40.09%
    -40.09%
    6 Month
    -50.98%
    -50.98%
    1 Year
    -18.92%
    -18.92%

    More News

    Read More
    Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    $100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
    Via Benzinga
    What the Options Market Tells Us About DexCom
    Via Benzinga
    Is DexCom a Millionaire Maker?
    Via The Motley Fool
    Down More Than 50%, Is DexCom Stock a Bargain Now?
    Via The Motley Fool
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
    From The Rosen Law Firm PA
    Via GlobeNewswire
    DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
    Via The Motley Fool
    DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LONGSTANDING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Kirby McInerney LLP Notifies Investors of Lead Plaintiff Deadline in Dexcom Inc. (DXCM) Securities Class Action
    From Kirby McInerney LLP
    Via GlobeNewswire
    DexCom Inc. October 21, 2024 Lead Plaintiff Deadline – DXCM Investors Should Contact Robbins LLP for Information
    From Robbins LLP
    Via GlobeNewswire
    Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
    From DexCom, Inc.
    Via Business Wire
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    DexCom Is Great. Here's Why You Shouldn't Buy It.
    Via The Motley Fool
    Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against DexCom, Inc. (DXCM) – Deadline is October 21, 2024
    From Kaplan Fox & Kilsheimer LLP
    Via Business Wire
    Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
    From DexCom, Inc.
    Via Business Wire
    DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.